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Biﬁdobacteria represent one of the dominant groups of micro-
organisms colonizing the human infant intestine. Commensal
bacteria that interact with a eukaryotic host are believed to express
adhesive molecules on their cell surface that bind to speciﬁc host
cell receptors or soluble macromolecules. Whole-genome transcrip-
tion proﬁling of Biﬁdobacterium biﬁdum PRL2010, a strain isolated
from infant stool, revealed a small number of commonly expressed
extracellular proteins, among which were genes that specify
sortase-dependent pili. Expression of the coding sequences of
these B. biﬁdum PRL2010 appendages in nonpiliated Lactococcus
lactis enhanced adherence to human enterocytes through extra-
cellular matrix protein and bacterial aggregation. Furthermore,
such piliated L. lactis cells evoked a higher TNF-α response during
murine colonization compared with their nonpiliated parent, sug-
gesting that biﬁdobacterial sortase-dependent pili not only con-
tribute to adherence but also display immunomodulatory activity.
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The interaction between bacteria and their human host affectsthe latter in several ways. In some cases, this interaction may
impact negatively on the health status of the host (pathogenesis),
whereas in other cases may not inﬂuence host health at all
(commensalism). In addition, certain bacterium–host interactions
that represent symbiotic and probiotic relationships promote the
health status of the host (1). Currently, the molecular mecha-
nisms underlying the presumed health-promoting activities are
largely unknown, despite the widely held view that microbial
populations residing in the human gastrointestinal tract exert
activities that positively affect host health (2). Biﬁdobacteria
represent prominent commensals of the human infant gut (3)
where they modulate metabolic and immune activities of their
host (4–6). Through functional genomic approaches, signiﬁcant
progress has been made in unraveling biﬁdobacterial gut colo-
nization strategies (1). In a recent study, we found that the ge-
nome of Biﬁdobacterium biﬁdum PRL2010 harbors an extensive
gene set involved in the utilization of host-derived glycans, such
as those found in the outermost layer of the intestinal mucosa
(7). These ﬁndings are very suggestive of host-microbe coevo-
lution, and signify B. biﬁdum PRL2010 as a biﬁdobacterial pro-
totype for analysis of interactions between microbes and the
intestinal mucosa. Many commensal and pathogenic micro-
organisms that interact with eukaryotic hosts express adhesive
structures on their cell surface that mediate physical contacts
between such bacteria and speciﬁc host cell receptors or soluble
macromolecules (8). Bacterial surface appendages, such as pili
or ﬁmbrial adhesins in Gram-negative bacteria, have historically
been considered to be the predominant bacterial structures in-
volved in host–microbe interaction (8). Gene clusters responsible
for the biosynthesis of pili have been identiﬁed in the genomes of
many Gram-negative and Gram-positive bacteria, not only in
pathogens (9–12) but also in gut inhabitants, such as Lactoba-
cillus rhamnosus GG (13). Notably, sortase-dependent pili enco-
ded by L. rhamnosus GG were demonstrated to be pivotal for
efﬁcient adherence and immunomodulatory interactions with
human gut cells (14). In biﬁdobacteria, experimental evidence of
the existence of sortase-dependent and type IV pili was reported
only very recently (15, 16). Here, we describe in vivo analyses of
the gut commensal B. biﬁdum PRL2010, with a focus on the role
of sortase-dependent pili in host–microbe interaction.
Results and Discussion
Introduction of B. biﬁdum PRL2010 to the Murine Gut. Conventional
female BALB/c mice were administered a single daily dose of 109
CFU B. biﬁdum PRL2010 (SI Materials and Methods). Mice were
a priori checked for the presence of biﬁdobacteria in fecal
samples by PCR using Biﬁdobacterium-speciﬁc primers (17),
which revealed that biﬁdobacteria were either absent or below
the limit of detection. Animals were killed 12 d later, allowing
sufﬁcient time for several cycles of turnover of the intestinal
epithelium and its overlying mucus layer (18). Microbial evalu-
ation of the murine gut showed the presence of strain PRL2010
at stable numbers, reminiscent of at least transient colonization
over time with the highest numbers of this strain recorded in the
cecum and colon (Fig. S1). Given the robustness of its coloni-
zation of the distal gut, we focused on determining adaptations
of PRL2010 to the caecal habitat.
B. biﬁdum PRL2010 Transcriptome Under in Vitro and in Vivo Condi-
tions. To investigate possible interactions of PRL2010 with its
natural ecological niche, the gut, we performed global genome
transcription proﬁling of this strain in an in vitro human gut model
using HT29 cells, as well as upon colonization of PRL2010
of the murine gut using a custom-made B. biﬁdum PRL2010
array representing 90% of the identiﬁed genes of this organism
(7). The global gene expression proﬁle of B. biﬁdum PRL2010
was conserved in the caeca between different mice (Fig. 1A).
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According to a principal component analysis, these proﬁles were
clearly different from the transcriptomes of PRL2010 obtained
under in vitro conditions (HT29 monolayer or laboratory cul-
tures) (Fig. 1B). This ﬁnding suggests, not unexpectedly, dis-
tinctly different transcriptional responses of PRL2010 to each
of these environments. A total of 104 or 62 genes exhibited
a ≥twofold change (P < 0.0005) in transcription upon bringing
PRL2010 cells in contact with HT29 cells, using the tran-
scriptome of PRL2010 grown in DMEM or Man-Rogosa-Sharp
(MRS) synthetic medium as a reference, respectively (Fig. S1B).
Analysis of the transcriptome of PRL2010 obtained when this
microorganism was present in the cecum of conventional BALB/
c mice showed that transcription of 87 or 141 genes was in-
creased more than twofold compared with their transcription
level in PRL2010 cells when obtained from the caecal contents
of mice fed on fresh Chow diet or when grown on MRS, re-
spectively. The comparative analysis shown in Fig. 1A and Fig.
S1B yielded three groups of regulated genes, including those
speciﬁc to in vivo conditions (group 1), to in vitro experiments
(i.e., exposure to a human cell line, group 2), and to growth in
synthetic medium under laboratory conditions (group 3). We
also categorized genes from these three groups into three sub-
groups based on whether the genes were contributed from a single
environmental condition (i.e., human cell line model, in vivo,
or synthetic media datasets) (subgroups A), or two conditions
(subgroups B), or all three conditions (subgroup C) (Fig. 1C).
Assignment of genes into these groups may reﬂect bacterial
responses to differences in host structures. These differences
could be species-speciﬁc (human vs. murine), tissue-speciﬁc (co-
lon vs. cecal mucosa), or they could also be linked to differential
carbohydrate availability or to the effect of the residential in-
testinal microorganisms. We used cluster of orthologous groups
(COG) analysis to identify differentially transcribed genes that
contribute to speciﬁc biological functions. As illustrated in Fig.
1D, carbohydrate metabolism, corresponding to COG category
[G], is one of the COG functions of PRL2010 most signiﬁcantly
affected by the interaction with the murine host, which is probably
because of a response to the presence of speciﬁc host glycans, in
particular mucin (7). Various members of this COG function
were signiﬁcantly up-regulated (≥twofold; P < 0.0005) under in
vivo conditions, encompassing genes involved in breakdown of
glycoproteins (Fig. 1A).
PRL2010 cell surface properties also appear to be modiﬁed in
response to tissue contact, as indicated by the increased tran-
scription of genes encoding several extracellular and membrane-
spanning proteins, many of which are predicted to mediate in-
teraction with eukaryotic cells (Fig. 1E). Adhesion of bacteria
to human intestinal mucosa or extracellular matrix (ECM) pro-
teins represents a key strategy for intestinal colonization, and
biﬁdobacteria can indeed adhere to intestinal cells (19, 20).
Genes that specify putative adhesion functions for PRL2010 in-
clude BBPR_0641, which speciﬁes a putative elastin-binding
protein and whose transcription was signiﬁcantly induced under
in vivo conditions as well as upon exposure to HT29 cells (18-
to 24-fold). It is known that elastin-binding proteins promote
recognition of mammalian ECM, thus allowing colonization
of the host by gut bacteria (21). Furthermore, transcription of
BBPR_0651, whose protein product displays similarity to early
secretory antigen target 6 (ESAT-6), was shown to be highly in-
duced following HT29 exposure and when PRL2010 was present in
the murine gut. The small ESAT-6 protein appears to be of fun-
damental importance in virulence and protective immunity in My-
cobacterium tuberculosis and Staphylococcus aureus (22), suggesting
that the homologous protein of PRL2010 acts as a protective im-
munity determinant. PRL2010 contact with HT29 cells and its
presence in mice also triggered the transcription of another gene
(BBPR_0699), predicted to encode a protein involved in the bio-
synthesis of teichoic acids, which for Lactobacillus acidophilus
NCFM have been shown to modulate host–microbe interaction
(23). Two of the three pilus clusters identiﬁed on the PRL2010
genome (7, 15) [i.e., pil2PRL2010 (BBPR_1707-BBPR_1709),
and pil3PRL2010 (BBPR_282-BBPR_284)] were shown to be
expressed under both in vitro and in vivo conditions. Notably,
and in contrast to the adjacent pilin subunit-encoding genes
(BBPR_1707 and BBPR_1708), BBPR_1709, which speciﬁes a
predicted sortase, was shown to be expressed when PRL2010 was
grown in MRS medium, suggesting that this sortase also processes
other cell wall-anchored proteins. This ﬁnding is supported by
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Fig. 1. Identiﬁcation of B. biﬁdum PRL2010 differentially expressed genes
by transcriptome analysis in response to contact with the host. (A) Heat-map
displaying the change in PRL2010 gene expression upon colonization of
murine caeca (lanes 1 and 2), when grown in DMEM synthetic medium (lanes
3) or in fresh chow diet (lane 4), and following incubation with human in-
testinal HT29 cells (lanes 5 and 6). Each row represents a separate transcript
and each column represents a separate sample. Color legend is on the bot-
tom of the microarray plot; green indicates increased transcription levels
compared with the reference samples. The reference conditions used were
as follows: lane 1, fresh chow diet; lanes 2–4 and 6, MRS medium; lane 5,
DMEM. Dendrogram on the left margin of the heat-map represents the
hierarchical clustering algorithm result based on average linkage and Eu-
clidean distance of the gene dataset. (B) The clustering of PRL2010 tran-
scriptomes under in vitro and in vivo conditions by principal component
analysis. (C) Venn diagram showing the number of genes expressed during
the different conditions: in vitro (exposure to a human cell line), in vivo, and
DMEM synthetic medium. (D) Depiction of a functional annotation of the in
vitro- and in vivo-expressed genes of B. biﬁdum PRL2010 according to their
COG categories. Each COG family is identiﬁed by a one-letter abbreviation
(National Center for Biotechnology Information database). For each cate-
gory, the black bar represents the percentage of genes in that category as
detected in the sequenced genome of PRL2010 (7). The other bar shows the
percentages of genes transcribed during murine colonization by PRL2010
(conditions 1 and 2), and following exposure of PRL2010 cells to human
intestinal cells (conditions 5 and 6). The percentage was calculated as the
percentage of transcribed genes belonging to the indicated COG category
with respect to all transcribed genes. (E) Selected genes that were up-reg-
ulated when PRL2010 were cultivated in the conditions indicated in A.
11152 | www.pnas.org/cgi/doi/10.1073/pnas.1303897110 Turroni et al.
a previously reported ﬁnding that the BBPR_1709 gene is tran-
scribed separately from the other components of this pilus gene
cluster (15). The predicted pilus proteins are similar to subunits
of so-called sortase-dependent pili, which are typically com-
posed of a major pilin subunit (represented by FimAPRL2010 or
FimPPRL2010 for the pil2PRL2010 and pil3PRL2010 clusters, re-
spectively), and one or two ancillary minor pilin subunits (rep-
resented by FimBPRL2010 and FimQPRL2010 for the pil2PRL2010 and
pil3PRL2010 clusters, respectively) (Fig. S2) (15). When we com-
pared FimAPRL2010 to FimA homologs encoded by other B. biﬁ-
dum strains, their amino acid sequences were shown to display
much higher variability compared with the FimP homologs (Fig.
S2). In addition, FimAPRL2010 contains a CnaB-type domain,
which is described to act as a stalk in binding to components of
the ECM of the host, such as ﬁbronectin, collagen types I to XV,
and laminin (24). Atomic force microscopy (AFM) assays of
PRL2010 cells that had been exposed to human cell lines (Caco-2
or HT29) revealed a highly piliated cell morphology (Fig. S3B).
Interestingly, we found by AFM that pili were also present in
PRL2010 cultivated in liquid media or on agar plates, although
pili appeared to be less abundant compared with the numbers
seen upon contact with a human cell line (Fig. S3 A–D). Fur-
thermore, Western blot analysis using antibodies that had been
raised against the major subunit protein of the pil2 or pil3 loci,
FimAPRL2010 and FimPPRL2010, respectively (Abpil2 or Abpil3) (SI
Materials and Methods) was performed on PRL2010 cells that
had been in contact with Caco-2 monolayers or cultivated on agar
plates. Clear signals representing a protein of 55.87 kDa and
55.43 kDa were noticed when a crude extract of PRL2010 cells,
previously exposed to Caco-2 monolayers, was probed in a
Western blot using Abpil2 or Abpil3, respectively (Fig. S3E). In
contrast,Western blot signals of lower intensity were observed using
protein extracts from PRL2010 cultivated on agar plates or MRS
plus lysine. The higher molecular weight signals above 100 kDa
detected in each immunoblot image (Fig. S3E) likely represent the
covalently linked polymers of FimA2010 and FimP2010, a typical
feature of sortase-dependent pili (12, 25).
Differential Binding to Human Epithelial Cells Mediated by PRL2010
Pili. To obtain further insight into the functional roles exerted by
pili encoded by PRL2010, we expressed the pil2PRL2010 and
pil3PRL2010 gene clusters in the Gram-positive host Lactococcus
lactis NZ9000 (SI Materials and Methods), because genetic ma-
nipulation of PRL2010, such as creating knockout mutants, is
currently not possible. L. lactis has previously been used suc-
cessfully as a heterologous host for expression of biﬁdobacterial
proteins (26, 27), as well as a host to display full-length forms of
microbial surface structures (28). AFM analysis revealed that
both L. lactis-pil2PRL2010 and L. lactis-pil3PRL2010 clones dis-
played evident piliated morphology when pilus expression had
been induced with nisin, but no pili were observed in noninduced
L. lactis controls (Fig. S4 A–C). Furthermore, the cell surface of
(nisin-induced) L. lactis-pil2PRL2010 and L. lactis-pil3PRL2010 clones
was less densely piliated than that of the wild strain B. biﬁdum
PRL2010 (Figs. S3 A–D and S4 B and D).
Based on previous ﬁndings for analogous structures in Acti-
nomyces oris (29), we decided to evaluate possible interactions
between B. biﬁdum PRL2010 pili structures and a Caco-2 human
intestinal epithelial cell line, to establish if they are involved
in bacterial adhesion to human enterocytes. To this aim, we used
L. lactis-pil2PRL2010 and L. lactis-pil3PRL2010 cells in adhesion ex-
periments using a Caco-2 differentiated cell layer. Remarkably,
following nisin induction L. lactis-pil3PRL2010 displayed a signiﬁ-
cant enhancement in adhesion to eukaryotic cells compared
with noninduced L. lactis-pil3PRL2010 (Fig. 2 A and B). In
contrast, L. lactis-pil2PRL2010 cells did not display any signiﬁcant
change in adhesion properties under the conditions tested (Fig. 2
C and D). A clear adhesion phenotype was also noticed in the
wild-type strain B. biﬁdum PRL2010 (Fig. 2 E and F); the ob-
served Caco-2-adhesive behavior was displayed by PRL2010,
which is clearly more pronounced than that observed for nisin-
induced L. lactis-pil2PRL2010 cells, and which may be because of
the elevated abundance of pili structures in PRL2010 cells
compared with those produced in the heterologous host, or the
result of the presence of additional adhesion promoting cell-
surface molecules on PRL2010, such as BopA (19). These results
therefore demonstrate direct involvement of biﬁdobacterial
sortase-dependent pili structures in mediating adhesion to hu-
man intestinal cells, thus implicating these extracellular struc-
tures in host colonization by the infant intestinal commensal
B. biﬁdum PRL2010. To substantiate these ﬁndings, competitive
adhesion assays involving piliated L. lactis-pil3PRL2010 cells that
had ﬁrst been treated with Abpil3, were performed. This experi-
ment showed that treatment with Abpil3 decreased adhesion
of piliated L. lactis-pil3PRL2010 cells to Caco-2 cells by maximum
17-fold (P < 0.05) (Fig. 2G).
Bacterial Aggregation and PRL2010 Pili. Sortase-assembled pili are
also known to promote bacterial coaggregation (30). We therefore
investigated if a similar scenario would apply to the B. biﬁdum
PRL2010 pili. We performed aggregation experiments involving
piliated L. lactis-pil3PRL2010, L. lactis-pil2PRL2010, and their non-
piliated L. lactis equivalent strains. Notably, in the case of nisin-
induced L. lactis-pil2PRL2010 and L. lactis-pil3PRL2010 cells (from
here on referred as piliated L. lactis-pil2PRL2010 and L. lactis-
pil3PRL2010 cells), aggregation levels enhanced 13- and 21-fold
with respect to their uninduced equivalents (P < 0.05) (from here
on referred as nonpilated lactis-pil2PRL2010 and L. lactis-
pil3PRL2010 cells), respectively (Fig. S5). Taken together, these
data implicate Pil2PRL2010 and Pil3PRL2010 as important factors
that promote bacterial autoaggregation, possibly with a contrib-
uting role in gut colonization. These ﬁndings corroborate the
view that bacterial aggregation represents a mechanism by which
gastrointestinal commensals adhere to each other and, as a result,
may colonize persistently in bioﬁlms on the host’s mucosa (31).
Human Receptors for PRL2010 Pili. Although we identiﬁed sortase-
dependent pili as a PRL2010 adhesion factor that mediates
binding to epithelial cells, the receptors involved in their rec-
ognition are unknown. As enteropathogens are known to adhere
to intestinal tissue by pili-mediated binding to ECM proteins
(32–34), we examined the ability of PRL2010 to adhere to the
ECM proteins ﬁbrinogen, plasminogen, ﬁbronectin, laminin, and
collagen type IV. Notably, B. biﬁdum PRL2010 cells showed
higher adhesion to ﬁbronectin, plasminogen, and laminin, com-
pared with the other ECM proteins (Fig. 3A). A similar scenario
was noticed when piliated L. lactis-pil3PRL2010 as well as L. lactis-
pil2PRL2010 clones were used. In contrast, nonpiliated L. lactis
cells displayed very limited adhesion to these ECM substrates, as
conﬁrmed by microscopic examination of the samples (Fig. 3A).
Binding of piliated L. lactis-pil3PRL2010 and L. lactis-pil2PRL2010
cells to serial dilutions of ECM substrates was evaluated, show-
ing that saturation of binding already occurred at low concen-
trations of the ECM protein tested (Fig. S6). To evaluate
whether the binding of B. biﬁdum PRL2010 to ﬁbronectin, which
appeared to be the most effective ECM substrate, occurs for
strains besides our reference strain, other biﬁdobacterial strains
were tested. Notably, within the B. biﬁdum species, strain
PRL2010 displayed the highest adhesion level, whereas other
biﬁdobacterial strains belonging to Biﬁdobacterium breve, Biﬁ-
dobacterium adolescentis, and Biﬁdobacterium longum subsp.
infantis, displayed much lower levels of binding to ﬁbronectin,
plasminogen, and laminin (Fig. 3B), which may reﬂect different
strategies used by these bacteria to colonize the human gut. All
these strains except B. longum subsp. infantis ATCC15697 en-
code putative sortase-dependent pili, and they were treated
and cultivated under the same conditions as PRL2010. Consid-
ering that ﬁbronectin is a glycoprotein and that carbohydrate
residues have been shown to be involved in ﬁmbrial binding to
ﬁbronectin (35), we addressed the possible involvement of ﬁ-
bronectin-associated glycans in PRL2010 pili binding. Fibro-
nectin deglycosylation of O-linked and N-linked oligosaccharides
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caused a signiﬁcant reduction in PRL2010 pili-mediated binding
ability compared with untreated ﬁbronectin (Fig. 3c), suggesting
that N- and O-linked glycoproteins are involved in adhesion of
PRL2010 pili to ﬁbronectin. Because it was previously shown
that certain carbohydrates bind to sortase-dependent pili, thereby
competing with the actual pilus receptor (32, 33, 35), we evaluated
the effect of various carbohydrates on binding of PRL2010 Pil2
and Pil3 to ﬁbronectin. Interestingly, we found that the binding of
this ECM protein to piliated L. lactis-pil2PRL2010 was signiﬁcantly
reduced when mannose or fucose was present during the binding
assay. Binding ability of piliated L. lactis-pil3PRL2010 was also af-
fected by glucose and galactose, but not by the polysaccharide
xylan (Fig. 3D). This ﬁnding suggests that mannose and fucose act
as potential receptors for Pil2 of B. biﬁdum PRL2010 reminiscent
of the pili behavior of enteric bacteria (32, 33, 35), whereas the
putative receptors of Pil3 seem to include a wider spectrum of
carbohydrates.
Immunomodulatory Activity Exerted by PRL2010 Pili. Similar to other
extracellular structures encoded by several enteropathogens col-
onizing the human gut (36), we wanted to explore the possible
roles played by B. biﬁdum PRL2010 pili in triggering (aspects of)
the immune system of its human host. When we assayed the im-
pact of the L. lactis clones producing Pil2PRL2010 and Pil3PRL2010
on cytokine expression by human macrophage-like cell line U937,
we noticed a different cytokine modulation exerted by Pil2 and
Pil3. Notably, piliated L. lactis-pil3PRL2010 clones displayed a sig-
niﬁcant induction (10-fold; P < 0.05) of the TNF-α mRNA levels
compared with nonpiliated L. lactis-pil3PRL2010 (Fig. S7A). In
contrast, piliated L. lactis-pil2PRL2010 clones did not appear to
have any effect on the expression of the four cytokines that we
assessed (Fig. S7A). Presence or absence of PRL2010 pili might
therefore explain the difference in TNF-α response. To test this
possibility directly, the TNF-α response was measured in chal-
lenging mice treated with piliated L. lactis-pil3PRL2010 cells.
Pili of PRL2010 Affect the Cytokine Proﬁles in a Mouse Model. To
investigate the role of sortase-dependent pili in PRL2010 colo-
nization in mammals, piliated L. lactis-pil3PRL2010 and non pili-
ated L. lactis-pil3PRL2010 were used in murine models. To mimic
the natural route of gut microbial colonization, a 109 CFU dose
of microencapsulated lactococci (to prevent pili removal from
L. lactis during gastric transit) was orally administered daily to
12-wk-old BALB/c mice. Production of pili was induced before
microencapsulation of lactococci by the addition of nisin (SI
Materials and Methods). Furthermore, to ensure proper delivery
of piliated/nonpiliated lactococci, we used alginate microencap-
sulation, which is known to release encapsulated bacteria fol-
lowing gastric transit (37). Mice were killed 4 h following the last
lactococcal administration, and cytokine expression proﬁles were
determined (Fig. S7B). Notably, under these in vivo conditions
the piliated L. lactis-pil3PRL2010 evoked TNF-α expression and
a signiﬁcantly lower IL-10 response compared with the non-
piliated L. lactis-pil3PRL2010 (Fig. S7B) in murine cecum mucosa
samples. These results reinforce the notion that pili of PRL2010
can inﬂuence the host innate immunity in a similar manner as
previously outlined for other human gut commensals, such as
Bacteroides (38).
Reportedly, and in accordance with our results, biﬁdobacteria
can be strong inducers of TNF-α but weak inducers of other
proinﬂammatory cytokines (39, 40), which are more speciﬁcally
involved in mounting responses at systemic level, such as IL-12
(41, 42). Therefore, the immunomodulatory effects elicited by
PRL2010 Pil3 may be delimited at local level, as previously
suggested for other biﬁdobacterial strains, potentially because of
insufﬁcient induction of antigen-presenting cell maturation (41,
42). More speciﬁcally, a local induction of TNF-α could be im-
portant for the initiation of cross-talk among immune cells
without causing any inﬂammation or detrimental effects (43).
Conclusions
Various ecological studies have demonstrated that biﬁdobacteria
are a dominant bacterial group of the (human) infant gut
microbiota, as well as part of the intestinal microbiota of an adult
human being (3, 17). However, relatively little is known about
the molecular basis sustaining their ability to colonize the human
gut and to interact with the intestinal mucosa. Biﬁdobacteria
arguably use a variety of mechanisms that may facilitate inter-
actions with the intestinal mucosa at different life stages of the
host, but perhaps also pertaining to different compartments of
the gastrointestinal tract of the host (5, 16). The intimate at-
tachment to the intestinal mucosa is presumed to be pivotal to
allow colonization by gut commensals. Here, we describe the
presence of a number of extracellular protein-encoding genes
whose transcription is speciﬁcally up-regulated when our model
bacterium B. biﬁdum PRL2010 was placed in contact with
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Fig. 2. Adhesion of B. biﬁdum PRL2010 sortase-assembled pili to human
intestinal cells. (A and B) Display of the adhesion phenotype of nonpiliated
(A) and piliated (B) L. lactis-pil3PRL2010 cells to the Caco-2 cell monolayer. (C
and D) The adhesion phenotype of nonpiliated (C) and piliated (D) L. lactis-
pil2PRL2010 cells to the Caco-2 cell monolayer. (E) The adhesion of B. biﬁdum
PRL2010 cells to Caco-2 cell monolayer. (F) The adhesion efﬁciency (adhesion
index) of B. biﬁdum PRL2010, piliated (black pillar) and nonpiliated (blue
pillar) L. lactis-pil2PRL2010 cells, as well as L. lactis-pil3PRL2010 cells de-
termined in terms number of adhered bacterial cells per 100 Caco-2 cells. The
negative control is represented by B. animalis subsp. lactis BB12 cells. (G)
Depiction of inhibition pili-mediated adhesion to the Caco-2 cell monolayer
by L. lactis-pil3PRL2010 cells, which had ﬁrst been treated with anti-pil3 anti-
bodies (Abpil3). Piliated L. lactis-pil3PRL2010 cells (black pillar) and nonpiliated
(blue pillar) L. lactis-pil2PRL2010 cells were used. Two different concentrations
of antibodies were used. +, Represents the use of diluted (1:50) Abpil3; ++,
undiluted Abpil3. Bars represent mean values of three independent experi-
ments, and the error bars indicate the SD (P < 0.05).
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human cell lines or when present in the murine gut. Remarkably,
among these speciﬁc host-induced genes we identiﬁed two loci
that encode sortase-dependent pili. These appendages that
decorate the bacterial surface are considered key molecules in
mediating bacterial adherence to the host epithelium and may
thus inﬂuence mucosal immune responses (12, 44). It was re-
cently shown that type IV or Tad pili encoded by B. breve
UCC2003 are required for colonization and persistence of this
bacterium in the murine gut (16). However, in the case of
B. biﬁdum PRL2010, the role of Tad pili in gut colonization and gut
adhesion is currently not known. The genes that are responsible
for the biosynthesis of the Tad pili are strictly conserved within
biﬁdobacterial genomes, but the gene clusters that specify sortase-
dependent pili production vary in number and sequence, and may
thus represent strain-speciﬁc pili combinations. Thus, in contrast to
Tad pili, sortase-dependent pili may impart unique features to a
biﬁdobacterial strain among the complex microbiota present in the
human gut, such as modulating speciﬁc host-microbe responses. In
this context we noticed that piliated L. lactis-pil3PRL2010 clones
evoked a higher TNF-α response during mouse colonization,
compared with nonpiliated L. lactis-pil3PRL2010 clones, suggesting
that PRL2010 pili not only contribute to adherence but also act as
immunogenic effectors. Triggering of increased TNF-α production
by pili encoded by B. biﬁdum PRL2010 may be an interesting
feature of this species as one of the ﬁrst colonizers of the human gut
(3). In fact, cytokines belonging to the TNF-α superfamily are not
only linked to the occurrence of inﬂammatory diseases (45), but
also play a role in the rejection of tumors and the response to
infections (46, 47). In addition, the induction of TNF-α may be
important for the initiation of cross-talk among immune cells
without causing any inﬂammation or detrimental effects (43). In
fact, the infant’s immune system is immature and the presence of
proinﬂammatory stimuli, such as those exerted by pili encoded by
B. biﬁdum, may be crucial in developmental immunological pro-
gramming. In this context, it is well known that decreased antigenic
exposure has adverse effects on the budding immune system and
increases the likelihood of developing atopic disorders (48). In
addition, a transient inﬂammatory state could aid host defense.
Thus, as recently suggested, the difference between pathogenic and
gut commensal bacteria is in the magnitude of the immune re-
sponse evoked, which can be deﬁned as strong, intermediate or
homeostatic (49).
The genome of B. biﬁdum PRL2010 encompasses three dif-
ferent loci encoding predicted sortase-dependent pili, of which
only pil2 and pil3 appear to be functional as one of the pilus
subunit-encoding genes of pil1 contains a frameshift (15). Here,
we have shown that expression of pil2 and pil3 enhances adher-
ence to enterocytes and modulates the host inﬂammatory re-
sponse (for pil3), but it also promotes bacterial aggregation (for
pil2). A possible model explaining the role of pili in host-
PRL2010 interactions envisages an initial attachment of planc-
tonic PRL2010 cells to the enterocytes by extending their pili,
either sortase-dependent or Tad pili, toward the apical surface of
the host cells. This initial adhesion to enterocytes is followed by
a more intimate attachment driven by the establishment of the
linkage between pili and speciﬁc host receptors, such as host-
glycoproteins. In addition, pilus-mediated PRL2010 aggregation
further assists the formation of a microbial community in the
proximity of the colonized enterocytes. Pil2 and Pil3 were shown
to exhibit different binding abilities with respect to carbohy-
drates, where Pil2 is able to adhere to typical mammalian gut
carbohydrates, which appear to include fucose and mannose, and
Pil3 showed an apparent ability to adhere to a wider set of car-
bohydrates, many of which would be expected to be present in
the diet, thus suggesting that such diet-derived carbohydrates
modulate PRL2010 gut colonization. Colonization as a result of
a wide variety of host and bacterial factors, together with in-
creased bacterial cell density, can lead to an enhanced innate
immune response. This ﬁnding is in line with the notion that
mammals depend on critical gene products from their gut
microbiota to fully develop their immune system (50). Hence,
the presence or absence of distinct B. biﬁdum sortase-dependent
pili may represent pivotal molecules in colonization and persis-
tence within the human gut, and may have a profound effect in
terms of the developmental programming of the host immune
system, which is in line with observations previously noted for
other gut symbionts (51).
Materials and Methods
B. biﬁdum PRL2010 and L. lactis were manipulated and used as described in SI
Materials and Methods. Detailed descriptions of bacterial strains, plasmids,
and oligonucleotides (Table S1) used in this study, as well as methods for gene
expression analyses, AFM investigations, bacterial adhesion assays, activation
of human macrophage cell line, murine trials, and Western blot experiments
are provided in SI Materials and Methods. The transcriptional array data have
been deposited in the GEO database under accession no. GSE36442.
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Fig. 3. Involvement of pili produced by B. biﬁdum PRL2010 in binding to
ECM proteins. (A) Adhesion of B. biﬁdum PRL2010 cells, L. lactis-pil2PRL2010
cells, and L. lactis-pil3PRL2010 cells to various ECM proteins. Below each pillar
a picture is placed to indicate how piliated and nonpiliated L. lactis-
pil2PRL2010 cells and L. lactis-pil3PRL2010 cells appeared under the microscope
following exposure to ECM substrates. For each of these experiments, ad-
hesion of microbial cells to BSA was used as negative control. Piliated
PRL2010 represent PRL2010 cells grown under conditions that promote the
production of sortase-dependent pili (cells grown on MRS agar or grown to
stationary phase in MRS broth plus lysine), and nonpiliated PRL2010 repre-
sent PRL2010 cells grown under conditions that reduce production of sor-
tase-dependent pili (cells grown in MRS broth to exponential phase). (B)
Adhesion of different biﬁdobacterial strains to ﬁbronectin, plasminogen
and laminin. (C) Adhesion of piliated L. lactis-pil2PRL2010- and L. lactis-
pil3PRL2010 cells to deglycosylated ﬁbronectin. (D) Adhesion ability of piliated
L. lactis-pil2PRL2010 and L. lactis-pil3PRL2010 to ﬁbronectin in the presence of
different carbohydrates. Bars represent mean values for three independent
experiments, and the error bars indicate the SD (P < 0.05).
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SI Text
Bacterial Strains and Culture Conditions. Biﬁdobacterial cultures
were incubated in an anaerobic atmosphere [2.99% (vol/vol) H2,
17.01% (vol/vol) CO2, and 80% (vol/vol) N2] in a chamber (Con-
cept 400, Ruskin) in the Man-Rogosa-Sharp (MRS) (Scharlau
Chemie) supplemented with 0.05% (wt/vol) L-cysteine hydrochlo-
ride and incubated at 37 °C for 16 h. Lactococcus lactis was rou-
tinely cultured at 30 °C in GM17 (M17 supplemented with 0.5%
glucose) for 16 h. Microencapsulation of lactococci was performed
as previously described (1). To facilitate the inclusion of lactococci
in a polymer shell, microencapsulation was performed using a co-
extrusion method, which had been previously optimized for the
production of water-in-water hydrogel microbeads (1, 2).
Sample Preparation and Atomic Force Microscopy Imaging. Bacteria
from four ml bacterial culture or obtained following contact
with Caco-2 or HT29 were harvested by centrifugation and
resuspended in 200 μL of PBS (or 20 mM Hepes 7.5, 1 mM
EDTA). Next, 200 μL of 5% glutaraldehyde was added, followed
by gentle mixing and incubation for 1 min at room temperature.
Thereafter, bacteria were washed four times with PBS by re-
peated resuspension and collection by centrifugation (1,700 × g).
The washed pellet was then resuspended in 200 μL of PBS and
kept on ice until atomic force microscopy (AFM) imaging. To
facilitate adhesion of bacteria to the mica support used for AFM
imaging, mica was coated with polylysine as follows: 10 μL of
a polylysine solution (10 ng/mL) was deposited onto freshly
cleaved mica for 1 min. Mica was then rinsed with milliQ water
(Millipore) and dried with nitrogen. After this process, 20 μL of
bacterial suspension was deposited onto polylysine-coated mica
for 2–5 min, depending on the particular strain or speciﬁc cul-
tivation conditions. The mica disk was then rinsed with milliQ
water and dried under a weak gas ﬂow of nitrogen. Quality of the
sample and density of surface-bound bacteria were veriﬁed with
an optical microscope.
AFM imaging was performed on dried samples with a Nano-
scope III microscope (Digital Instruments) equipped with scan-
ner J and operating in tapping mode. Commercial diving board
silicon cantilevers (MikroMasch) were used. Best image quality
was obtained with high driving amplitude (1–3 V) and low scan
rate (0.5 Hz). Filamentous structures at the periphery of bacteria
were visible in images of 512 × 512 pixels, representing a scan
size of 10 μm or less. While imaging both height and ampli-
tude signals were collected, height images were ﬂattened using
Gwyddion software.
Cloning of Pili-Encoding Genes in L. lactis. Chromosomal DNA was
isolated from Biﬁdobacterium biﬁdum PRL2010 as previously
described (3). Minipreparation of plasmid DNA from L. lactis
was achieved using the Qiaprep spin plasmid miniprep kit (Qia-
gen) as described previously (4). Single-stranded oligonucleotide
primers used in this study were synthesized by MWG Biotech.
Standard PCRs were performed using TaqPCR mastermix (Qia-
gen), and high-ﬁdelity PCR was achieved using KOD polymerase
(Novagen). PCR fragments were puriﬁed using the Qiagen PCR
puriﬁcation kit (Qiagen). Electroporation of plasmid DNA into
L. lactis was performed as described by Wells et al. (5).
For the construction of plasmids pNZ8150-pil2, pNZ8048-pil3
and pNZEM-SRTBBPR_0285 DNA fragments encompassing the
pil2 (BBPR_1709-BBPR_1707), pil3 (BBPR_0282-BBPR_0283)
or srtBBPR_0285 (BBPR_0284) genes were generated by PCR
ampliﬁcation from chromosomal DNA of B. biﬁdum PRL2010
using KOD polymerase and primer combinations pil2F and
pil2R, pil3F and pil3R, or pil3srtF and pil3srtR, respectively
(Table S1). NcoI or EcoRV, and XbaI restriction sites were in-
corporated at the 5′ ends of each forward and reverse primer
combination, respectively (Table S1). The four generated am-
plicons were digested with NcoI/EcoRV and XbaI, and ligated
into NcoI/ScaI- and XbaI-digested nisin-inducible translational
fusion plasmids pNZ8048, pNZ8150, or pNZ8048-Em as ap-
propriate (6). The ligation mixtures were introduced into
L. lactis NZ9000 by electrotransformation, and transformants were
selected based on chloramphenicol resistance for pNZ8048 and
pNZ8150, or erythromycin resistance for pNZ8048-EM trans-
formants. The plasmid content of a number of transformants was
screened by restriction analysis and the integrity of positively
identiﬁed clones was veriﬁed by sequencing. For the construction
of pNZ-pil2BBPR1707, pNZ-pil3BBPR0282, or pNZ-pil3BBPR0283,
DNA fragments of the pilin-encoding genes, BBPR_1707,
BBPR_0282, and BBPR_0283, without the signal sequence-
encoding DNA were ampliﬁed with 1707F and 1707R, 282F and
282R, or 283F and 283R (Table S1), respectively. These DNA
fragments represent codons 30–517 of BBPR_1707, codons 40–
1137 of BBPR_0282, and codons 30–495 of BBPR_0283. NcoI
and XbaI restriction sites were incorporated at the 5′ end of each
forward and reverse primer combination, respectively (Table S1).
In addition, an in-frame His10-encoding sequence was incorpo-
rated into each of the forward primers to facilitate downstream
protein puriﬁcation using the Ni-NTA afﬁnity system (Qiagen).
The three generated amplicons were digested with NcoI and
XbaI, and ligated into similarly-digested, nisin-inducible trans-
lational fusion plasmid pNZ8048 (6). The ligation mixtures were
introduced into L. lactis NZ9000 by electrotransformation, and
transformants were selected based on chloramphenicol resis-
tance. The plasmid content of a number of Cmr transformants was
screened by restriction analysis and the integrity of positively
identiﬁed clones was veriﬁed by sequencing.
Protein Overproduction and Puriﬁcation. M17 broth (400 mL)
supplemented with 0.5% glucose was inoculated with a 2% in-
oculum of a particular L. lactis strain, followed by incubation at
30 °C until an optical density (OD at wavelength 600 nm) of 0.5
was reached, at which point protein expression was induced by
the addition of puriﬁed nisin (5 ng·mL−1) followed by continued
incubation at 30 °C for 90 min. Cells were harvested by centri-
fugation, washed and concentrated 40-fold in lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole; pH 8.0). Cell ex-
tracts were prepared using 106-μm glass beads and the minibead-
beater-8 cell disrupter (Biospec Products). After homogenization,
the glass beads and cell debris were removed by centrifugation,
and the supernatant containing the cytoplasmic fractions was
retained. Protein puriﬁcation from the cytoplasmic fraction was
performed using Ni-NTA matrices in accordance with the manu-
facturer’s instructions (Qiagen). Elution fractions were analyzed
by SDS/PAGE, as described by Laemmli (7), on a 12.5% poly-
acrylamide gel. After electrophoresis the gels were ﬁxed and
stained with Commassie Brilliant blue to identify fractions con-
taining the puriﬁed protein. Rainbow prestained low molecular
weight protein markers (New England Biolabs) were used to es-
timate the molecular weight of the puriﬁed proteins.
Preparation of Antisera. Antiserum speciﬁc for FimAPRL2010
(AbFimA), and FimPPRL2010 (AbFimP) recombinant His-tagged
proteins were produced by Eurogentec according to their standard
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procedures. In brief, for each protein groups of two rabbits were
injected subcutaneously with a 1-mL volume of 400 μg puriﬁed
recombinant BBPR_1707 or BBPR_0283 proteins and Freund’s
complete adjuvant (1:1 mixture). One milliliter of subcutaneous
booster injections of 200 μg of BBPR_1707 or BBPR_0283
protein in Freund’s incomplete adjuvant (1:1 mixture) were ad-
ministered at 3-wk intervals over a 9-wk period. Blood was col-
lected 14 d after the last booster injection and the antiserum was
prepared.
Western Blotting. Overnight cultures were harvested by centrifu-
gation and resuspended in lysis buffer (100 mM NaH2PO4, 10
mM Tris·Cl, 8 M urea pH 8). This bacterial cell suspension was
then subjected to sonication using six 10-s bursts at 200–300 W
with a 10-s cooling period between each burst. Lysed bacteria
were then centrifuged at 3,500 × g for 2 min, the pellets were
resuspended in 60 μL Sample Buffer (Laemmli), and boiled
at 100 °C for 15 min. Proteins were separated on a 10% SDS-
polyacrylamide gel and then transferred onto a 0.2 μm pore size
nitrocellulose membrane (Bio-Rad), using a wet/tank blotting
apparatus (Bio-Rad Criterion Blotter). The membrane was
successively blocked overnight at 4 °C in TBS supplemented with
0.05% Tween 20 (TBST) containing 5% skim milk powder
(blocking solution). Membranes were washed three times with
TBST for 15 min and then incubated with the polyclonal anti-
body AbFimA or FimP AbFimP (diluted 1:5,000 in TBST) for 2 h
at room temperature. Immunoblots were then washed three
times for 15 min with TBST followed by incubation with LiCor
IRDye 680 Goat anti-rabbit for 1 h. Immunodetection was
performed with the Odyssey Infrared Imager (LiCor).
Bioinformatics Analyses. The estimation of the sequence diversity
was established from the calculation of the average π of differ-
ences between pairs of sequences, or from the number of segre-
gation sites (Watterson’s estimator θ). The nucleotide diversity π
(8) the Watterson’s estimator θ (9) were computed using DnaSP
4.10 (10), using a sliding window length of 100 bp shifted by 25 bp
at each sliding step.
RNA Isolation. Total RNA was isolated using a previously de-
scribed method (11). Brieﬂy, cell pellets/tissue materials were
resuspended in 1 mL of QUIAZOL (Qiagen) and placed in a tube
containing 0.8 g of glass beads (diameter, 106 μm; Sigma). The
cells were lysed by shaking the mix on a BioSpec homogenizer at
4 °C for 2 min (maximum setting). The mixture was then centri-
fuged at 15,000 × g for 15 min, and the upper phase containing the
RNA-containing sample was recovered. The RNA sample was
further puriﬁed by phenol extraction and ethanol precipitation
according to an established method (12). The quality of the RNA
was checked by analyzing the integrity of rRNA molecules by
Experion (Bio-Rad).
Microarray, Description, Labeling, and Hybridizations. Microarray
analysis was performed with an oligonucleotide array based on the
B. biﬁdum PRL2010 genome: a total of 39,249 oligonucleotide
probes of 35 bp in length were designed on 1,644 ORFs using
OligoArray 2.1 software (13). The Oligos were synthesized in
triplicate on a 2 × 40k CombiMatrix array (CombiMatrix).
Replicates were distributed on the chip at random, nonadjacent
positions. A set of 74 negative control probes designed on phage
and plant sequences were also included on the chip.
Reverse transcription and ampliﬁcation of 500 ng of total RNA
was performed with MessageAmp II-Bacteria kit (Ambion)
according to the manufacturer’s instructions. Five micrograms of
RNA was then labeled with ULS Labeling kit for Combimatrix
arrays with Cy5 (Kreatech). Hybridization of labeled DNA to
B. biﬁdum PRL2010 arrays was performed according to Com-
biMatrix protocols (www.combimatrix.com).
Microarray Data Acquisition and Treatment. Fluorescence scanning
was performed on an InnoScan 710microarray scanner (Innopsys).
Signal intensities for each spot were determined using GenePix
Pro-7 software (Molecular Devices). Signal background was
calculated as the mean of negative controls plus two times the SD
(14). A global quantile normalization was performed (15) and
log2 ratios between the reference sample and the test samples
were calculated. The distribution of the log2-transformed ratios
was separately calculated for each hybridization reaction.
Study of the Activation of U937 Human Macrophage Cell Line. Cell
line U937 (ATCC CRL-1593.2) was derived from a human his-
tiocytic lymphoma (16). For immunological experiments on hu-
man U937 macrophages, bacterial cells from an overnight
culture were collected, washed twice with sterile PBS, and then
resuspended in the same medium used to culture human cells.
Bacteria were tested at a multiplicity of infection of 10 and 100.
To prevent underestimation of the number of cells used because
of the coaggregation exerted by PRL2010 pili, L. lactis-pil2PRL2010
and L. lactis pil3PRL2010 cells were enumerated through the use of
a Petroff–Hausser counting chamber and normalized prior the
induction of pili by the addition of nisin as mentioned above.
U937 cells are maintained as replicative, nonadherent cells and
have many of the biochemical and morphological characteristics
of blood monocytes (17). When treated with phorbol myristate
acetate, U937 cells differentiate to become adherent, nonrepli-
cative cells with characteristics similar to tissue macrophages,
including similar isoenzyme patterns (18) and other phenotypic
markers (17). The normal growth medium for the U937 cells
consisted of RPMI medium 1640 (Lonza) supplemented with
10% (vol/vol) FBS (FBS) (Gibco-BRL, Life Technologies), 2
mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL strepto-
mycin (Sigma-Aldrich). U937 cells were seeded at a density of
5 × 105 cells/well in 12-well plates and incubated at 37 °C in
a humidiﬁed atmosphere of 95% air and 5% CO2. Differentia-
tion was induced by the addition of phorbol myristate acetate
(Sigma-Aldrich) into the cellular medium at a ﬁnal concentra-
tion of 100 nM and was allowed to proceed for 48 h. Following
this, cells were washed once with sterile PBS buffer to remove all
nonadherent cells. One hour before the bacteria were added to
the cells, the culture medium was replaced with RPMI 1640
supplemented with 1% (vol/vol) FBS to allow the cells to adapt.
Bacteria were used at a multiplicity of infection of 10 and 100.
An untreated sample [i.e., only RPMI medium 1640 with 1%
(vol/vol) FBS] was used as control.
Preparation of RNA and Reverse Transcription. Following incubation
of macrophages at 37 °C for 4 h, the supernatant was carefully
removed from each well and total cellular RNA was isolated
from the adhered cells with a Bio-Rad Aurum Total RNA Fatty
and Fibrous Tissue Pack kit. RNA concentration and purity was
then determined with a Bio-Rad Smart Spec Spectrophotometer
and the quality and integrity of the RNA was checked by Ex-
perion (Bio-Rad) analysis. Reverse transcription to cDNA was
performed with the iScript Select cDNA Synthesis Kit (Bio-Rad
Laboratories) using the following thermal cycle: 5 min at 25 °C,
30 min at 42 °C, and 5 min at 85 °C. The mRNA expression levels
of cytokines were analyzed with SYBR Green technology in RT-
quantitative PCR using SoFast EvaGreen Supermix (Bio-Rad)
on a Bio-Rad CFX96 system according to the manufacturer’s
instructions (Bio-Rad). The primers used are indicated in Table
S1. Quantitative PCR was carried out according to the following
cycle: initial hold at 96 °C for 30 s and then 40 cycles at 96 °C for
2 s and 60 °C for 5 s. Gene expression was normalized to the
housekeeping gene coding for the18S rRNA. The amount of
template cDNA used for each sample was 12.5 ng. All results
regarding cytokine mRNA expression levels are reported as
the fold-of-induction in comparison with the control (namely
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unstimulated macrophages), to which we attributed an fold-of-
induction of 1.
Tissue-Culture Experiments. All cell-culture reagents unless speci-
ﬁed otherwise were from Sigma-Aldrich. For cell culture
experiments, 2 × 105 Caco-2 or HT29 cells in 1.5 mL of DMEM
(high glucose, Hepes) medium supplemented with 10% heat-
inactivated FBS (Gibco), penicillin (100 U/mL), streptomycin
(0.1 mg/mL) and amphotericin B (0.25 μg/mL), and 4 mM
L-glutamine were seeded into the upper compartments of a six-well
transwell plate (Corning). The lower compartments contained
3.0 mL of the same medium. The cells were incubated at 37 °C in
a 5% CO2 atmosphere until they reached 3 d postconﬂuence.
The cells were then washed with Hanks’ solution and stepped-
down in DMEM supplemented with L-glutamine (4 mM), so-
dium selenite (0.2 μg/mL), and transferrin (5 μg/mL) for 24 h.
These transwell inserts were transferred to an anaerobic culture
box within an MACS-MG-1000 anaerobic workstation at 37 °C
and each insert ﬁlled with anaerobic DMEM cell medium. A
culture of B. biﬁdum PRL2010 at exponential phase was har-
vested by centrifugation at 3,500 × g for 5 min and washed with
10 mL of anaerobic DMEM. The pellet was resuspended in 0.8
mL of the same medium. Next, 100 μL of bacterial suspension
(108 cfu/mL) was added to experimental wells; the control wells
received the same amount of medium without bacterial cells. As
an additional control bacterial cells incubated without Caco-2
and HT29 cells was used.
Bacterial cells were harvested for analyses after 4 h of in-
cubation. Microbial cells were collected into 1.5-mL tubes,
centrifuged at 3,500 × g for 5 min, and the resulting pellet re-
suspended in 400 μL of RNAlater and submitted to RNA ex-
traction following the protocol described above. Caco-2 cells or
HT29 cells were harvested from the wells, pooled, and stored in
RNA later at 4 °C.
Bacterial Adhesion to Caco-2 Cells. Caco-2 cells were routinely
grown in 3-cm Petri plates on microscopy cover glasses in DMEM
supplemented with 10% (vol/vol) heat-inactivated (30 min at
56 °C) FCS, 100 U/mL penicillin, 100 mg/mL streptomycin, 0.1
mM nonessential amino acids, 2 mM L-glutamine (complete
medium), and incubated at 37 °C in a water-jacketed incubator
in an atmosphere of 95% air and 5% carbon dioxide. The culture
medium was changed twice weekly. For adhesion assay experi-
ments, cells were used 15 d after conﬂuence (fully differentiated
cells). Cell monolayers were carefully washed twice with PBS
pH 7.3 (PBS) before addition of bacterial cells. The bacterial cell
concentration of an overnight culture was determined microscop-
ically with Neubauer Improved counting chamber (Marienfeld).
Approximately 2 × 108 cells for each strain were incubated with
a monolayer of fully differentiated Caco-2 cells. After 1 h at 37 °C
in anaerobic conditions, all monolayers were washed three times
with PBS to release unbound bacteria. Cells were then ﬁxed with
3 mL of methanol and incubated for 8 min at room temperature.
After removal of methanol, cells were stained with 3 mL of
Giemsa stain solution (1:20) (Carlo Erba) and left 30 min at room
temperature. Wells were then washed until no color was observed
in the washing solution and dried in an incubator for 1 h. Mi-
croscopy cover glasses were then removed from the Petri plate
and examined microscopically (magniﬁcation, 100×) under oil
immersion. The adherent bacteria in 20 randomly selected mi-
croscopic ﬁelds were counted and averaged.
Inhibition of the Pili-Mediated Adhesion Using Anti-Pili Antibodies.
Before the adhesion assay on polarized Caco-2 cells, L. lactis-
pil3PRL2010 (nisin-induced or uninduced) cells were incubated at
room temperature for 1 h with or without Abpil3. Two different
concentrations of Abpil3 were considered: 50 μl of undiluted
Abpil3 or 50 μl of 1:50 diluted Abpil3 were added to 1 mL of
bacterial suspension containing 108 cells in PBS (pH 7.3). Fol-
lowing incubation, bacterial cells were washed once with PBS
and tested in adhesion experiments as described above.
Bacterial Aggregation. L. lactis clones and biﬁdobacterial species
were incubated at 30 °C to 37 °C respectively in M17 and MRS
broth, respectively. Pili synthesis in L. lactis clones were induced
by the addition of nisin as described above. After incubation for
3 and 24 h, 1 mL of the upper suspension was transferred to
another tube and the OD was measured at 600 nm. The aggre-
gation was expressed as follows: 1 − (OD upper suspension/OD
total bacterial suspension) × 100 (19).
Quantiﬁcation of Bacterial Binding to Extracellular Matrix Proteins.
Ninty-six MicroWell plates (Maxisorp Nunc) were coated with
a solution of 500 μg/mL of extracellular matrix (ECM) protein in
100 μL PBS (PBS). The ECM proteins used included ﬁbrinogen,
plasminogen, ﬁbronectin, laminin, and collagen type IV, which
were purchased from Sigma. Unbound protein was removed
by washing the plates two times with PBS containing and was
subsequently blocked with 1% BSA (BSA) in PBS for 30 min at
37 °C. The blocking buffer was removed, and the wells were
washed twice before the addition of bacterial cells in a 100-μL
ﬁnal volume. Incubation with the bacteria was performed for 1 h
at growth bacterial temperature. After the wells were washed
with PBS, the bacterial cells that adhered to the wells were
collected by scraping them into PBS with 0.5% (vol/vol) Triton
X-100; serial dilutions were plated onto MRS or GM17 agar
plates. The number of adherent bacteria was determined by
counting the resulting colonies in duplicate. Deglycosylation of
nondenatured ﬁbronectin was carried out by digestion at 37 °C
for 4 d with N-glycanase, Sialidase A, O-glycanase, β1,4-galacto-
sidase, and β-N-acetylglucosaminidase according to the manu-
facturer’s protocols (Prozyme). To evaluate the role of mannose,
fucose, galactose, glucose, and xylan on adhesion of the pili en-
coded by PRL2010, bacteria were incubated in PBS with 1% of
each of the above mentioned carbohydrates.
Light Microscopy.Glass coverslips were coated with each ECM as
described above. After washing with PBS, 100 μL of PBS con-
taining ∼1 × 108 bacteria was added, and the plate was incubated
at 30 °C for 1 h. After ﬁxation samples were rinsed with PBS
to remove the unbound bacterial cells and then analyzed by
light microscopy.
Murine Colonization. All animals used in this study were cared for
in compliance with guidelines established by the Italian Ministry
of Health. All procedures were approved by the University of
Parma, as executed by the Institutional Animal Care and Use
Committee (Dipartimento per la Sanità Pubblica Veterinaria, la
Nutrizione e la Sicurezza degli Alimenti Direzione Generale
della Sanità Animale e del Farmaco Veterinario). Two groups,
each containing ﬁve animals of 3-mo-old female BALB/c mice,
were orally inoculated with bacteria. Bacterial colonization was
established by ﬁve consecutive daily administrations whereby
each animal received a dose of 109 cells using a micropipette tip
placed immediately behind the incisors (20). Bacterial inocula
were prepared by feeding mice with 109 CFU doses of B. biﬁdum
PRL2010 or by microencapsulated lactococci.
To estimate the number of B. biﬁdum PRL2010 cells per gram
of feces, individual fecal samples were serially diluted and cul-
tured on selective agar (MRS) containing 3 μg/mL chloram-
phenicol. Following enumeration of B. biﬁdum PRL2010 in fecal
samples, 100 random colonies were further tested to verify their
identity using PCR primers targeting the pil2 and pil3 loci (21).
Animals were killed by cervical dislocation and their individual
gastrointestinal tracts were removed, immediately treated with
RNA-later and subsequently used for RNA extraction.
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In vivo evaluation of the immune-modulatory activities exerted
by sortase-dependent pili encoded by PRL2010 was performed
by daily supplementation of two groups of ﬁve mice each with
microencapsulated piliated L. lactis-pil3PRL2010 and microencap-
sulated nonpiliated L. lactis-pil3PRL2010 for 3 d. Production of pili
was induced before microencapsulation of lactococci through the
addition of nisin to the culture as mentioned above. To prevent
underestimation of cell numbers because of coaggregation,
L. lactis-pil2PRL2010 and L. lactis pil3PRL2010 cells were enu-
merated by means of a Petroff–Hausser counting chamber and
normalized prior the induction of pili by the addition of nisin as
mentioned above. Four hours from the last lacococcal adminis-
tration, mice were killed and cecum sections were removed and
stored in RNAlater, were diluted 1:1 in an equal volume of sterile
PBS, followed by centrifugation at 5,000 × g for 10 min at 4 °C.
Statistical Analysis. Statistical signiﬁcance between means was
analyzed using the unpaired Student t test with a threshold P <
0.05. Values are expressed as the means ± the SEMs of three
experiments. Multiple comparisons are analyzed using one-way
ANOVA and Bonferroni tests. Statistical calculations were
performed using the software program GraphPad Prism 5.
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Fig. S1. Population sizes of B. biﬁdum PRL2010 colonizing the intestine of BALB/c mice (A) and Venn diagram representing the genes expressed under in vivo
conditions, upon contact with Caco-2 cells and in synthetic media using different reference conditions (B). In A, each point represents the average of the log-
transformed population size ± SD for ﬁve mice. In B the numbering of the cluster refers to the conditions described in Fig. 1.
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Fig. S2. Schematic comparative representation of pilus-encoding loci of B. biﬁdum PRL2010. Each arrow indicates an ORF, the size of which is proportional to
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Fig. S3. Pili production of PRL2010 cultivated under different growth conditions. (A and B) PRL2010 cell’s morphology upon cultivation on solid substrate (A,
MRS agar) and exposure to Caco-2 cells (B). (C and D) PRL2010 cell’s morphology upon cultivation in liquid medium supplemented with lysine (C, MRS broth plus
lysine) and solid substrate enriched with lysine (D, MRS agar plus lysine). (E) Western blot analyses using crude extracts of PRL2010 cells upon cultivation on
MRS broth (lane 4), or treatment with Caco-2 cells (lane 3), or growth on MRS agar (lane 2), or cultivation on MRS broth plus lysine (lane 1). The antibodies used
are indicated below each immunoblot image.
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Fig. S4. Cell morphology of L. lactis clones expressing PRL2010 pili assayed by AFM. (A and B) L. lactis-pil2PRL2010 cell morphology before (A) and after (B)
treatment with nisin. (B and C) L. lactis-pil3PRL2010 cell morphology by AFM before (C) and after (D) treatment with nisin.
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Table S1. Primers used in this study
Primer Sequence (5′–3′)
pil2F CTGGACGATATCATGCCGGCATCGTCGAAGACCATC
pil2R TGCGCATCTAGACTCATCGCCGTTCCTTTCCGTATG
pil3F CTGGACCCATGGTGGAAGGGATGCTTATCGTG
pil3R AGCTCTCTAGATCAGACGAGCCGACGCTTGCG
pil3srtF CTGGACCCATGGGCATGGCATCGAGGAG
pil3srtF TGCGCATCTAGATCACCCACGCATGCGCCAC
1707F GACAAGCCATGGAGCATCACCATCACCATCACCATCACCATCACGTCGTCACGGACGGTGAGAAG
1707R AGCTCTCTAGAGCATCCGTCAGACCGTTC
282F GACAAGCCATGGAGCATCACCATCACCATCACCATCACCATCACGACAGCAGTGATCCGAAGGGC
282F AGCTCTCTAGATCAGACGAGCCGACGCTTGCG
283F GACAAGCCATGGAGCATCACCATCACCATCACCATCACCATCACGCATACAAGATCGCGGACTAC
283F AGCTCTCTAGAGTTATCGTGTCAGTCAGCGCAG
18S rRNA -F ATCCCTGAAAAGTTCCAGCA
18S rRNA-R CCCTCTTGGTGAGGTCAATG
IL-10- F AGCAGAGTGAAGACTTTCTTTC
IL-10-R CATCTCAGACAAGGCTTGG
TNF-α-F AACTAATGGGAGTTGCCTGG
TNF-α-R CCACCTGGTACATCTTCAAGTC
IL-1β-F AGCTTGGTGATGTCTGGTCCA
IL-1β-R ACACGCAGGACAGGTACAGATT
IL-RA-F GTACCCATTGAGCCTCATGCT
IL-1RA-R GTTCTCGCTCAGGTCAGTGATG
IL-12p35-F AACTAATGGGAGTTGCCTGG
IL-12p35-R CCACCTGGTACATCTTCAAGTC
IL-4-F AGCTTCTCCTGATAAACTAATTGCC
IL-4-R CAGCAAAGATGTCTGTTACGG
IL-6-F GAACCTTCCAAAGATGGC
IL-6-R CAAATCTGTTCTGGAGGT
IL-8-F GAGTGCTAAAGAACTTAGATGTCAG
IL-8-R AAACTTCTCCACAACCCTC
IFN-γ-F CAGGTCATTCAGATGTAGC
IFN-γ-R CACCGAATAATTAGTCAGC
Restriction enzyme sequences incorporated into forward and reverse primers are indicated in bold. His-tag encoding sequences
incorporated into forward primers are indicated in italics.
Turroni et al. www.pnas.org/cgi/content/short/1303897110 10 of 10
